1 Speiler BD, Meadow SR. Maternal epilepsy and abnormalities of the fetus and newborn. The Lancet 1972; 2:839.
2 Barillon A, Grand A, Gerbaux A. Therapeutique cardiologique et grossesse. Ann Med Interne 1974; 125:437.
3 De Wolf D, De Schepper J, Verhaaren H et al. Congenital hypothyroid goiter and amiodarone. Acta Pediatr Scand 1988; 77:616.
4 Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation - 5ème édition. Williams & Wilkins 2003.
5 Shaxted EJ, Milton PJ. Disopyramide in pregnancy: a case report. Curr Med Res Opin 1979; 6:70.
6 Rotmensch HH, Elkayam U, Frishman W. Antiarrhythmic drug therapy during pregnancy. Ann Intern Med 1983; 98:487.
7 Leonard RF, Braun TE, Levy AM. Initiation of uterine contractions by disopyramide during pregnancy. N Engl J Med 1978; 299:84
8 Tadmor OP, Keren A, Rosenak D, Gal M, Shaia M, Hornstein E, Yaffe H, Graff E, Stern S, Diamant YZ. The effect of disopyramide on uterine contractions during pregnancy. Am J Obstet Gynecol 1990; 162:482.
9 Compendium Suisse des Médicaments. Documed SA, Bâle 2004.
10 Shepard TH. Catalog of Teratogenic Agents - 8ème édition. Johns Hopkins Press, Baltimore 1995.
11 Kogan BA, Iwamoto HS. Lower urinary tract function in the sheep fetus: studies of autonomic control and pharmacologic responses of the fetal bladder. J Urol 1989; 141:1019.
12 American Academy of Pediatrics, Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 2001; 108:776.
13 Bonnot O, Vollset SE, Godet PF, d'Amato T, Dalery J, Robert E. In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam ?. Encephale 2003; 29:553.
14 Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton MA, USA 1977.
15 Wood SM, Blainey JD. Prescribing in pregnancy. Hypertension and renal disease. Clin Obstet Gynaecol 1981; 8:439.
16 Coustan DR, Mochizuki TK. Handbook for Prescribing Medications During Pregnancy - 3ème édition. Lippincott-Raven 1998.
17 Senior B, Slone D, Shapiro S, Mitchell AA, Heinonen OP. Benzothiadiazides and neonatal hypoglycaemia. The Lancet 1976; 2:377.
18 Gray MJ. Use and abuse of thiazides in pregnancy. Clin Obstet Gynecol 1968; 11:568.
19 Alstatt LB. Transplacental hyponatremia in the newborn infant : Report of 4 cases. J Pediatr 1965; 66:985.
20 Anderson GG, Hanson TM. Chronic fetal bradycardia: possible association with hypokalemia. Obstet Gynecol 1974; 44:896.
21 Landers DV, Green JR, Sweet RL. Antibiotic use during pregnancy and the postpartum period. Clin Obstet Gynecol 1983; 26:391.
22 Christianson R, Page EW. Diuretic drugs and pregnancy. Obstet Gynecol 1976; 48:647.
23 Messina M, Biffignandi P, Ghigo E, Jeantet MG, Molinatti GM. Possible contraindication of spironolactone during pregnancy. J Endocrinol Invest 1979; 2:22.
24 Nakatsuka T, Komatsu T, Fujii T. Axial skeletal malformations induced by acetazolamide in rabbits. Teratology 1992; 45:629.
25 Burgess GE. Alpha blockade and surgical intervention of pheochromocytoma in pregnancy. Obstet Gynecol 1979; 53:266.
26 Redmond GP. Propranolol and fetal growth retardation. Sem Perinatol 1982; 6:142.
27 Mitrani A, Oettinger M, Abinader EG, Sharf M, Klein A. Use of propranolol in dysfunctional labour. Br J Obstet Gynaecol 1975; 82:651.
28 Tunstall ME. The effect of propranolol on the onset of breathing at birth. Br J Anaesth 1969; 41:892.
29 Bauer JH, Pape B, Zajicek J, Groshong T. Propranolol in human plasma and breast milk. Am J Cardiol 1979; 43:860.
30 Donchin Y, Amirav B, Sahar A, Yarkoni S. Sodium nitroprusside for aneurysm surgery in pregnancy. Report of a case. Br J Anaesth 1978; 50:849.
31 Lewis PE, Cefalo RC, Naulty JS, Rodkey FL. Placental transfer and fetal toxicity of sodium nitroprusside. Gyneco- logic Investigation 1977; 8:46.
32 Budnick IS, Leikin S, Hoeck LE. Effect in the newborn infant of reserpine administered ante partum. Am J Dis Child 1955; 90:286.
33 Broughton Pipkin F, Turner SR, Symonds EM. Possible risk with captopril in pregnancy: some animal data. The Lancet 1980; 1:1256.
34 Brent RL, Beckman DA. Angiotensin-converting enzyme inhibitors, an embryopathic class of drugs with unique properties: information for clinical teratology counselors. Teratology 1991; 43:543.
35 Guignard JP, Burgener F, Calame A. Persistent anuria in a neonate: a side effect of captopril ?. Int J Pediatr Nephrol 1981; 2:133.
36 Rothberg AD, Lorenz R. Can captopril cause fetal and neonatal renal failure?. Pediatr Pharmacol 1984; 4:189.
37 Knott PD, Thorpe SS, Lamont CA. Congenital renal dysgenesis possibly due to captopril. The Lancet 1989; 1:451.
38 Shotan A, Widerhorn J, Hurst A, Elkayam U. Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med 1994; 96:451.
39 The Medical Letter 1994; 16:67.
40 The Medical Letter 1995; 17:66.
41 Morris JA, Arce JJ, Hamilton CJ, Davidson EC, Maidman JE, Clark JH, Bloom RS. The management of severe preeclampsia and eclampsia with intravenous diazoxide. Obstet Gynecol 1977; 49:675.
42 Neuman J, Weiss B, Rabello Y, Cabal L, Freeman RK. Diazoxide for the acute control of severe hypertension complicating pregnancy: a pilot study. Obstet Gynecol 1979; 53:50S.
43 Milsap RL, Auld PA. Neonatal hyperglycemia following maternal diazoxide administration. JAMA 1980; 243:144.
44 Grauwiler J, Schon H. Teratological experiments with ergotamine in mice, rats, and rabbits. Teratology 1973; 7:227.
45 Wainscott G, Sullivan FM, Volans GN, Wilkinson M. The outcome of pregnancy in women suffering from migraine. Postgrad Med J 1978; 54:98.
46 The Medical Letter 1995; 17:27.
47 Mangurten HH, Benawra R. Neonatal codeine withdrawal in infants of nonaddicted mothers. Pediatrics 1980; 65:159.
48 Bonica JJ. Principles and Practice of Obstetric Analgesia and Anesthesia. Philadelphia, FA Davis 1967; 245.
49 Dayer P et al. Médicaments de référence. Med & Hyg 1994; 69:
50 Arwood LL, Dasta JF, Friedman C. Placental transfer of theophylline: two case reports. Pediatrics 1979; 63:844.
51 Yeh TF, Pildes RS. Transplacental aminophylline toxicity in a neonate. The Lancet 1977; 1:910.
52 Yurchak AM, Jusko WJ. Theophylline secretion into breast milk. Pediatrics 1976; 57:518.
53 Danielsson BR, Skold AC, Azarbayjani F. Class III antiarrhythmics and phenytoin: teratogenicity due to embryonic cardiax dysrhythmia and reoxygenation damage. Curr Pharm Des 2001; 7:787.
54 Marks TA, Terry RD. Developmental toxicity of ibutilide fumarate in rats after oral administration. Teratology 1996; 54:157.
55 Base de données Reprotox. Reproductive Toxicology Center, Bethesda 2004.
56 Smorlesi C, Caldarella A, Caramelli L, Di Lollo S, Moroni F. Topically Applied Minoxidil May Cause Fetal Malformation: A Case Report. Birth Defects Research 2003; 67:997.
57 Hohmann M, Kunzel W. Etilefrine and amezinium reduce uterine blood flow of pregnant guinea pigs. Eur J Obstet Gynecol Reprod Biol 1989; 30:173.
58 The Medical Letter 1994; 16:87.
59 Morton DM. Pharmacology and toxicology of nizatidine. Scand J Gastroenterol (suppl 136) 1987; 22:1.
60 Magee LA, Schick BRN, Donnenfeld AE, Sage SR et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. American Journal of Obstetrics and Gynecology 1996; 174:823.
61 Martinovic J, Benachi A, Laurent N, Daïkha-Dahmane F, Gubler MC. Fetal toxic effects and angiotensin-II-receptor antagonists. The Lancet 2001; 358:241.
62 Saji H, Yamanaka M, Hagiwara A, Ijiri R. Losartan and fetal toxic effects. The Lancet 2001; 357:363.
63 Lambot MA, Vermeylen D, Noël JC. Angiotensin-II-receptor inhibitors in pregnancy. The Lancet 2001; 357:1619.
64 Edison RJ. Central nervous system and limb anomalies in case reports of first-trimester statin exposure. N Engl J Med 2004; 350:1579.
65 Veyrac G, Chiffoleau A, Bailly C, Baudot S, Beaudoin S, Larousse C. Grossesse sous minoxidil en application cutanée: bébé poilu. Thérapie 1995; 50:463.
66 Warkany J, Takacs E. Experimental production of congenital malformations in rats by salicylate poisoning. Am J Pathol 1959; 35:315.
67 Slone D, Siskind V, Heinonen OP, Monson RR, Kaufman DW, Shapiro S. Aspirin and congenital malformations. The Lancet 1976; 1:1373.
68 Rudolph AM. Effects of aspirin and acetaminophen in pregnancy and in the newborn. Arch Intern Med 1981; 141:358.
69 Collins E. Maternal and fetal effects of acetaminophen and salicylates in pregnancy. Obstet Gynecol 1981; 58:57S.
70 Stuart MJ, Gross SJ, Elrad H, Graeber JE. Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis. N Engl J Med 1982; 307:909.
71 Hays DP: Teratogenesis: a review of the basic principles with a discussion of selected agents. Drug Intell Clin Pharm 1981; 15:
72 Schaefer C. Drugs during pregnancy and lactation. Elsevier 2001.
73 Romero R, Lockwood C, Oyarzun E, Hobbins JC. Toxemia: new concepts in an old disease. Semin Perinatol 1988; 12:302.
74 Levin DL. Effects of inhibition of prostaglandin synthesis on fetal development, oxygenation, and the fetal circulation. Semin Perinatol 1980; 4:35.
75 Fuchs F. Prevention of prematurity. Am J Obstet Gynecol 1976; 126:809.
76 Hickok DE, Hollenbach KA, Reilley SF, Nyberg DA. The association between decreased amniotic fluid volume and treatment with nonsteroidal anti-inflammatory agents for preterm labor. Am J Obstet Gynecol 1989; 160:1525.
77 Thomas H, Shepard MD. Catalog of Teratogenic Agents, 10th Edition. Johns Hopkins University Press 500 2001.
78 Ostensen M, Husby G. Antirheumatic drug treatment during pregnancy and lactation. Scand J Rheumatol 1985; 14:1.
79 Moise KJ Jr. Indomethacin therapy in the treatment of symptomatic polyhydramnios. Clin Obstet Gynecol 1991; 34:310.
80 Higby K, Xenakis EM, Pauerstein CJ. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol 1993; 168:1247.
81 Levin DL. Effects of inhibition of prostaglandin synthesis on fetal development, oxygenation, and the fetal circulation. Semin Perinatol 1980; 4:35.
82 Moise KJ Jr, Huhta JC, Sharif DS, Ou CN, Kirshon B, Wasserstrum N, Cano L. Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. N Engl J Med 1988; 319:327.
83 Itskovitz J, Abramovici H, Brandes JM. Oligohydramnion, meconium and perinatal death concurrent with indomethacin treatment in human pregnancy. J Reprod Med 1980; 24:137.
84 Niebyl JR. Preterm parturition. Prostaglandin synthetase inhibitors. Semin Perinatol 1981; 5:274.
85 Saxen I. Associations between oral clefts and drugs taken during pregnancy. Int J Epidemiol 1975; 4:37.
86 Fairhead FW. Convulsions in a breast-fed infant after maternal indomethacin. The Lancet 1978; 2:576.
87 Rayburn WF, Zuspan FP, Schneider PJ, Andresen BD, Latiolais CJ. Drug Therapy in Obstetrics and Gynecology. Appleton-Century Crofts, Norwalk, Conn. 1982.
88 W, Rathke A, Leuschen MP, Chleborad J, Weidner W. Fentanyl citrate analgesia during labor. Am J Obstet Gynecol 1989; 161:202.
89 Johnson ES, Colley PS. Effects of nitrous oxide and fentanyl anesthesia on fetal heart-rate variability intra- and postoperatively. Anesthesiology 1980; 52:429.
90 Chang A, Wood C, Humphrey M, Gilbert M, Wagstaff C. The effects of narcotics on fetal acid base status. Br J Obstet Gynaecol 1976; 83:56.
91 Way WL, Costley EC, Way EL. Respiratory sensitivity of the newborn infant to meperidine and morphine. Clin Pharmacol Ther 1965; 6:454.
92 Zelson C, Lee SJ, Casalino M. Neonatal narcotic addiction. Comparative effects of maternal intake of heroin and methadone. N Engl J Med 1973; 289:1216.
93 Ostrea EM, Chavez CJ, Strauss ME. A study of factors that influence the severity of neonatal narcotic withdrawal. : J Pediatr 1976; 88:642.
94 Smialek JE, Monforte JR, Aronow R, Spitz WU. Methadone deaths in children. A continuing problem. JAMA 1977; 238:2516.
95 Hale TW, McDonald R, Boger J. Transfer of celecoxib into human milk. J Hum Lact 2004; 20:397.
96 Goetz RL, Bain RV. Neonatal withdrawal symptoms associated with maternal use of pentazocine. J Pediatr 1974; 84:887.
97 Scanlon JW. Letter: Pentazocine and neonatal withdrawal symptoms. J Pediatr 1974; 85:735.
98 Refstad SO, Lindbaek E. Ventilatory depression of the newborn of women receiving pethidine or pentazocine. A double-blind comparative trial. Br J Anaesth 1980; 52:265.
99 Janz D. Antiepileptic drugs and pregnancy: altered utilization patterns and teratogenesis. Epilepsia 1982; 23:S53.
100 Perkins RP. Hydrops fetalis and stillbirth in a male glucose-6-phosphate dehydrogenase-deficient fetus possibly due to maternal ingestion of sulfisoxazole a case report. Am J Obstet Gynecol 1971; 111:379.
101 Seip M. Growth retardation, dysmorphic facies and minor malformations following massive exposure to phenobarbitone in utero. Acta Paediatrica Scandinavica. 1976; 65:617.
102 Shapiro S, Hartz SC, Siskind V, Mitchell AA, Slone D, Rosenberg L, Monson RR, Heinonen OP. Anticonvulsants and parental epilepsy in the development of birth defects. The Lancet 1976; 1:272.
103 Van der Pol MC, Hadders-Algra M, Huisjes HJ, Touwen BC. Antiepileptic medication in pregnancy: late effects on the children's central nervous system development. Am J Obstet Gynecol 1991; 164:121.
104 Desmond MM, Schwanecke RP, Wilson GS, Yasunaga S, Burgdorff I. Maternal barbiturate utilization and neonatal withdrawal symptomatology. J Pediatr 1972; 80:190.
105 Reith H, Schafer H. Antiepileptics during pregnancy and lactation. Pharmacokinetic data. Dtsch Med Wochenschr 1979; 104:818.
106 Milkovich L, Van den Berg BJ. Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development. N Engl J Med 1974; 291:1268.
107 Crombie DL, Pinsent RJ, Fleming DM, Rumeau-Rouquette C, Goujard J, Huel G. Letter: Fetal effects of tranquilizers in pregnancy. N Engl J Med 1975; 293:198.
108 Onnis A, Grella P. The biochemical effects of drugs in pregnancy. West Sussex, England: Ellis Horwood Limited 1984.
109 Wilson JT, Brown RD, Cherek DR, Dailey JW, Hilman B, Jobe PC, Manno BR, Manno JE, Redetzki HM, Stewart JJ. Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences. Clin Pharmacokinet 1980; 5:1.
110 Safra MJ, Oakley GP Jr. Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. The Lancet 1975; 2:478.
111 Rementeria JL, Bhatt K. Withdrawal symptoms in neonates from intrauterine exposure to diazepam. : J Pediatr 1977; 90:123.
112 Gillberg C. Floppy infant syndrome and maternal diazepam. The Lancet 1977; 2:244.
113 Athinarayanan P, Pierog SH, Nigam SK, Glass L. Chloriazepoxide withdrawal in the neonate. Am J Obstet Gynecol 1976; 124:212.
114 Stirrat GM, Edington PT, Berry DJ. Letter: Transplacental passage of chlordiazepoxide. Br Med J 1974; 2:729.
115 Laegreid L, Olegard R, Walstrom J, Conradi N. Teratogenic effects of benzodiazepine use during pregnancy. J Pediatr 1989; 114:126.
116 Patrick MJ, Tilstone WJ, Reavey P. Diazepam and breast-feeding. The Lancet 1972; 1:542.
117 Ullberg S, Lindquist NG, Sjostrand SE. Accumulation of chorio-retinotoxic drugs in the foetal eye. Nature 1970; 227:1257.
118 Rumeau-Rouquette C, Goujard J, Huel G. Possible teratogenic effect of phenothiazines in human beings. Teratology 1976; 15:57.
119 Slone D, Siskind V, Heinonen OP, Monson RR, Kaufman DW, Shapiro S. Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol 1977; 128:486.
120 Hammond JE, Toseland PA. Placental transfer of chlorpromazine. Case report. Arch Dis Child 1970; 45:139.
121 Baskin CG, Law S, Wenger NK. Sulfadiazine rheumatic fever prophylaxis during pregnancy: does it increase the risk of kernicterus in the newborn?. Cardiology 1980; 65:222.
122 Dieulangard P, Coignet J, Vical JC. Sur un cas d’ecto phocomelia, peut etre d’origine medicamenteuse. Bull Fed Gynecol Obstet 1966; 18:85.
123 McCullar FW, Heggeness L. Limb malformations following maternal use of haloperidol. JAMA 1975; 231:62.
124 Van Waes A, Van de Velde E. Safety evaluation of haloperidol in the treatment of hyperemesis gravidum. J Clin Pharmacol 1969; 9:224.
125 Hanson JW, Oakley GP Jr. Letter: Haloperidol and limb deformity. JAMA 1975;231:26.
126 Zierler S, Purohit D. Prenatal antihistamine exposure and retrolental fibroplasia. Am J Epidemiol 1986; 123:192.
127 McBride WG. Limb deformities associated with iminodibenzyl hydrochloride. Med J Aust 1972; 1:492.
128 Idanpaan-Heikkila J, Saxen L. Possible teratogenicity of imipramine-chloropyramine. The Lancet 1973; 2:282.
129 Dolovich LR, Addis A, Régis Vaillancourt JM, Barry Power JD, Koren G, Einarson TR. Benzodiazepine use in pregnancy and major malformations or oral cleft : meta-analysis of cohort and case-control studies. BMJ 1998; 317:839.
130 Musa AB, Smith CS. Neonatal effects of maternal clomipramine therapy. Arch Dis Child 1979; 54:405.
131 Eggermont E. Withdrawal symptoms in neonates associated with maternal imipramine therapy. The Lancet 1973; 2:680.
132 Elia J, Katz IR, Simpson GM. Teratogenicity of psychotherapeutic medications. Psychopharmacol Bull 1987; 23:531.
133 Jarnerot G, Into-Malmberg MB, Esbjorner E. Placental transfer of sulphasalazine and sulphapyridine and some of its metabolites. Scand J Gastroenterol 1981; 16:693.
134 Nora JJ, Nora AH, Toews WH. Letter: Lithium, Ebstein's anomaly, and other congenital heart defects. The Lancet 1974; 2:594.
135 Rane A, Tomson G, Bjarke B. Effects of maternal lithium therapy in a newborn infant. J Pediatr 1978; 93:296.
136 Allan LD, Desai G, Tynan MJ. Prenatal echocardiographic screening for Ebstein's anomaly for mothers on lithium therapy. The Lancet 1982; 2:875.
137 Tunnessen WW Jr, Hertz CG. Toxic effects of lithium in newborn infants: a commentary. J Pediatr 1972; 81:804.
138 Mizrahi EM, Hobbs JF, Goldsmith DI. Nephrogenic diabetes insipidus in transplacental lithium intoxication. J Pediatr 1979; 94:493.
139 Stevens D, Burman D, Midwinter A. Letter: Transplacental lithium poisoning. The Lancet 1974; 2:595.
140 L'Hommedieu CS, Nicholas D, Armes DA, Jones P, Nelson T, Pickering LK. Potentiation of magnesium sulfate--induced neuromuscular weakness by gentamicin, tobramycin, and amikacin. J Pediatr 1983; 102:629.
141 Nakane Y. Congenital malformation among infants of epileptic mothers treated during pregnancy--the report of a collaborative study group in Japan. Folia Psychiatr Neurol Jpn 1979; 33:363.
142 Rating D, Nau H, Jager-Roman E, Gopfert-Geyer I, Koch S, Beck-Mannagetta G, Schmidt D, Helge H. Teratogenic and pharmacokinetic studies of primidone during pregnancy and in the offspring of epileptic women. Acta Paediatr Scand 1982; 71:301.
143 Rudd NL, Freedom RM. A possible primidone embryopathy. J Pediatr 1979; 94:835.
144 Murray ED. Nalidixic acid in pregnancy. Br Med J 1981; 282:224.
145 Fisher JB, Edgren BE, Mammel MC, Coleman JM. Neonatal apnea associated with maternal clonazepam therapy: a case report. Obstet Gynecol 1985; 66:34S.
146 Buehler BA, Delimont D, van Waes M, Finnell RH. Prenatal prediction of risk of the fetal hydantoin syndrome. N Engl J Med 1990; 322:1567.
147 Meadow SR. Anticonvulsant drugs and congenital abnormalities. The Lancet 1968; 2:1296.
148 Hanson JW, Buehler BA. Fetal hydantoin syndrome: current status. J Pediatr 1982; 101:816.
149 Lane PA, Hathaway WE. Vitamin K in infancy. J Pediatr 1985; 106:351.
150 Finch E, Lorber J. Methaemoglobinaemia in the newborn probably due to phenytoin excreted in human milk. J Obstet Gynaecol Br Emp 1954; 61:833.
151 Jones KL, Lacro RV, Johnson KA, Adams J. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989; 320:1661.
152 Paulson GW, Paulson RB. Teratogenic effects of anticonvulsants. Arch Neurol 1981; 38:140.
153 Bjerkedal T, Czeizel A, Goujard J, Kallen B, Mastroiacova P, Nevin N, Oakley G Jr, Robert E. Valproic acid and spina bifida. The Lancet 1982; 2:1096.
154 Nau H, Rating D, Koch S, Hauser I, Helge H. Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothers. J Pharmacol Exp Ther 1981; 219:768.
155 Bertollini R, Kallen B, Mastroiacovo P, Robert E. Anticonvulsant drugs in monotherapy. Effect on the fetus. European Journal of Epidemiology 1987; 3:164.
156 Belton EM, Jones RV. Haemolytic anaemia due to nalidixic acid. The Lancet 1965; 2:691.
157 Havelka J, Frankova A. Adverse effects of chloramphenicol in newborn infants. Cesk Pediatr 1972; 21:31.
158 Askrog V, Harvald B. Teratogenic effects of inhalation anesthetics. Nord Med 1970; 83:498.
159 Cohen EN, Bellville JW, Brown BW Jr. Anesthesia, pregnancy, and miscarriage: a study of operating room nurses and anesthetists. Anesthesiology 1971; 35:343.
160 Knill-Jones RP, Rodrigues LV, Moir DD, Spence AA. Anaesthetic practice and pregnancy. Controlled survey of women anaesthetists in the United Kingdom. The Lancet 1972; 1:1326.
161 Tomlin PJ. Health problems of anaesthetists and their families in the west midlands. Brit Med J 1979; 1:779.
162 Corbett TH, Cornell RG, Endres JL, Lieding K. Birth defects among children of nurse-anesthetists. Anesthesiology 1974; 41:341.
163 Hall JG, Pauli RM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980; 68:122.
164 Iturbe-Alessio I, Fonseca MDC, Mutchinik O et al. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 1986; 315:1390.
165 Nielsen GL, Sorensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ 2001; 322:266.
166 Li D-K, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003; 327:368.
167 Bennett PN et al. Drugs and Human Lactation - 2nd edition. Elsevier 1996.
168 Schüler L, Pastuszak A, Sanseverino MTV, Orioli IM, Brunoni D, Ashton-Prolla P, Silva Da Costa F, Giugliani R, Mallman Couto A, Brancher Brandao S, Koren G. Pregnancy outcome after exposure to misoprostol in Brazil: a prospective, controlled study. Reprod Toxicol 1999; 13:147.
169 Gonzalez CH, Marques-Dias MJ, Kim CA, Sugayama SMM, Da Paz JA, Huson SM, Holmes LB. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. The Lancet 1998; 351:1624.
170 Sterne J, Lavieuville M. Clinical investigation on the possible teratogenic effects of oral antidiabetics on the human fetus. Therapie 1964; 19:165.
171 Piacquadio K, Hollingsworth DR, Murphy H. Effects of in-utero exposure to oral hypoglycaemic drugs. The Lancet 1991; 338:866.
172 Friend JR. Prescribing in pregnancy. Diabetes. Clin Obstet Gynaecol 1981; 8:353.
173 Castro-Magana M, Cheruvanky T, Collipp PJ, Ghavami-Maibodi Z, Angulo M, Stewart C. Transient adrenogenital syndrome due to exposure to danazol in utero. Am J Dis Child 1981; 135:1032.
174 Rosa FW. Virilization of the female fetus with maternal danazol exposure. Am J Obstet Gynecol 1984; 149:99.
175 Johnson JW, Mitzner W, London WT, Palmer AE, Scott R. Betamethasone and the rhesus fetus: multisystemic effects. Am J Obstet Gynecol 1979; 133:677.
176 Stahlmann R, Korte M, Van Loveren H, Vos JG, Thiel R, Neubert D. Abnormal thymus development and impaired function of the immune system in rats after prenatal exposure to aciclovir. Arch Toxicol 1992; 66:551.
177 Kampmann JP, Hansen JM. Clinical pharmacokinetics of antithyroid drugs. Clin Pharmacokinet 1981; 6:401.
178 Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331:1173.
179 Milham S Jr. Scalp defects in infants of mothers treated for hyperthyroidism with methimazole or carbimazole during pregnancy. Teratology 1985; 32:321.
180 Wilson JG, Brent RL. Are female sex hormones teratogenic?. Am J Obstet Gynecol 1981; 141:567.
181 McConnell JB, Glasgow JF, McNair R. Effect on neonatal jaundice of oestrogens and progestogens taken before and after conception. Br Med J 1973; 3:605.
182 Bracken MB, Srisuphan W. Oral contraception as a risk factor for preeclampsia. Am J Obstet Gynecol 1982; 142:191.
183 Lonnerdal B, Forsum E, Hambraeus L. Effect of oral contraceptives on composition and volume of breast milk. Am J Clin Nutr 1980; 33:816.
184 Doll DC, Ringenberg QS, Yarbro JW. Management of cancer during pregnancy. Arch Intern Med 1988; 148:2058.
185 Jick H, Walker AM, Rothman KJ, Hunter JR, Holmes LB, Watkins RN, D'Ewart DC, Danford A, Madsen S. Vaginal spermicides and congenital disorders. JAMA 1981; 245:1329.
186 Nicholson HO. Cytotoxic drugs in pregnancy. Review of reported cases. J Obstet Gynaecol Br Commonw 1968; 75:307.
187 Abrutyn D, McKenzie BE, Nadaskay N. Teratology study of intravaginally administered nonoxynol-9-containing contraceptive cream in rats. Fertil Steril 1982; 37:113.
188 Mills JL, Harley EE, Reed GF, Berendes HW. Are spermicides teratogenic?. JAMA 1982; 248:2148.
189 Crawford JS. The effects of drugs used in labor on the fetus and newborn. Clin Pharmacol Ther 1963; 4:628.
190 Carroll JJ, Moir RS. Use of promethazine (phenergan) hydrochloride in obstetrics report of a two and one-half year survey. JAMA 1958; 168:2218.
191 Potts CR, Ullery JC. Maternal and fetal effects of obstetric analgesia. Intravenous use of promethazine and meperidine. Am J Obstet Gynecol 1961; 81:1253.
192 Gibson JP, Huffmann KW, Newberne JW. Preclinical safety studies with terfenadine. Arzneimittelforschung 1982; 22:1179.
193 Reyes MP, Ostrea EM Jr, Cabinian AE, Schmitt C, Rintelmann W. Vancomycin during pregnancy: does it cause hearing loss or nephrotoxicity in the infant?. Am J Obstet Gynecol 1989; 161:977.
194 American Thoracic Society. Medical Section of the American Lung Association: Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1986; 134:355.
195 Snider DE Jr, Powell KE. Should women taking antituberculosis drugs breast-feed?. Arch Intern Med 1984; 144:589.
196 Varpela E. On the effect exerted by first-line tuberculosis medicines on the foetus. Acta Tuberc Pneumol Scand 1964; 45:53.
197 Beard TC, Rickard MD, Goodman HT. Medical treatment for hydatids. Med J Aust 1978; 1:633.
198 Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995; 172:525.
199 Diasio RB, Lakings DE, Bennett JE. Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicity. Antimicrob Agents Chemother 1978; 14:903.
200 Rosa FW, Hernandez C, Carlo WA. Griseofulvin teratology, including two thoracopagus conjoined twins. The Lancet 1987; 1:171.
201 McElhatton PR, Garbis HM, Elefant E, Vial T, Bellemin B, Mastroiacovo P, Arnon J,, Rodriguez Pinilla E, Schaefer C, Pexieder T, Merlob P, Dal Verme S. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the european network of teratology information services (ENTIS). Reprod Toxicol 1996; 10:285.
202 de Moor RA, Mourad L, ter Haar J, Egberts AC. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy]. Ned Tijdschr Geneeskd 2003; 147:1370.
203 Altshuler LL, Cohen L, Szuba MP, Burt VK, Gitlin M, Mintz J. Pharmacologic management of psychiatrduring pregnancyic illness : dilemmas and guidelines. Am J Psychiatry 1996; 153:592.
204 Gardiner SJ, Kristensen JH, Begg EJ, Hackett LP, Wilson DA, Ilett KF, Kohan R, Rampono J. Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants. Am J Psychiatry 2003; 160:1428.
205 Polatti F. Sulpiride isomers and milk secretion in puerperium. Clin Exp Obstet Gynecol 1982; 9:144.
206 Gardiner SJ, Kirkpatrick CM, Begg EJ, Zhang M, Moore MP, Saville DJ. Transfer of metformin into human milk. Clin Pharmacol Ther 2003; 73:71.
207 Smith MT. Chloral hydrate warning. Science 1990; 250:359.
208 Sitruk-Ware R, Davey A, Sakiz E. Fetal malformation and failed medical termination of pregnancy. The Lancet 1998; 352:323.
209 Philipp BL, Merewood A, O'Brien S. Methadone and breastfeeding: new horizons. Pediatrics 2003; 111:1429.
210 Johnson PD, Dawson BV, Goldberg SJ. Cardiac teratogenicity of trichloroethylene metabolites. J Am Coll Cardiol 1998; 32:540.
211 Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile RT, Tenconi R. Methimazole embryopathy : delineation of the phenotype. Am J Med Genet 1999; 83:43.
212 Sanz EJ, De-las-Cuevas C, Kiuru A, Bate A, Edwards R. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome : a database analysis. The Lancet 2005; 365:482.
213 Ruchkin V, Martin A. SSRIs and the developing brain. The Lancet 2005; 365:451.
214 Diamond I, Anderson MM, McCreadie SR. Transplacental transmission of busulfan (myleran) in a mother with leukemia. Production of fetal malformation and cytomegaly. Pediatrics 1960; 25:85.
215 Sokal JE, Lessmann EM. Effects of cancer chemotherapeutic agents on the human fetus. JAMA 1960; 172:1765.
216 Jacobs C, Donaldson SS, Rosenberg SA, Kaplan HS. Management of the pregnant patient with Hodgkin's disease. Ann Intern Med 1981; 95:669.
217 Shotton D, Monnie IW. Possible tératogenic effect of chlorambucil on a human foetus. JAMA 1963; 186:74.
218 Steege JF, Caldwell DS. Renal agenesis after first trimester exposure to chlorambucil. South Med J 1980; 73:1414
219 Thompson J, Conklin KA. Anesthetic management of a pregnant patient with scleroderma. Anesthesiology 1983; 59:69.
220 Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000; 343:1608.
221 Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 2001; 153:961.
222 Schaefer C, Amoura-Elefant E, Vial T, Ornoy A, Garbis H, Robert E, Rodriguez-Pinilla E, Pexieder T, Prapas N, Merlob P. Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Serces (ENTIS). Eur J Obstet Gynecol Reprod Biol 1996; 69:83.
223 Loebstein R, Addis A, Ho E, Andreou R, Sage S, Donnenfeld AE, Schick B, Bonati M, Moretti M, Lalkin A, Pastuszak A, Koren G. Pregnancy outcome folloqing gestational exposure to fluoroquinolones: a multicenter prospective controlled study. Antimicrob Agents Chemother 1998; 42:1336.
224 Nguyen Tan Lung R, Granier M, Gaudry C, Kourilsky O. Cyclophosphamide during pregnancy: a safe prescription. J Gynecol Obstet Biol Reprod 1995; 24:314.
225 Lergier JE, Jimenez E, Maldonado N, Veray F. Normal pregnancy in multiple myeloma treated with cyclophosphamide. Cancer 1974; 34:1018.
226 Daly H, McCann SR, Hanratty TD, Temperley IJ. Successful pregnancy during combination chemotherapy for Hodgkin's disease. Acta Haematol 1980; 64:154.
227 Lowenthal RM, Funnell CF, Hope DM, Stewart IG, Humphrey DC. Normal infant after combination chemotherapy including teniposide for Burkitt's lymphoma in pregnancy. Med Pediatr Oncol 1982; 10:165.
228 Kim DS, Park MI. Maternal and fetal survival following surgery and chemotherapy of endodermal sinus tumor of the ovary during pregnancy: a case report. Obstet Gynecol 1989; 73:503.
229 Nantel S, Parboosingh J, Poon MC. Treatment of an aggressive non-Hodgkin's lymphoma during pregnancy with MACOP-B chemotherapy. Med Pediatr Oncol 1990; 18:143.
230 Greenberg LH, Tanaka KR. Congenital anomalies probably induced by cyclophosphamide. JAMA 1964; 188:423.
231 Toledo TM, Harper RC, Moser RH. Fetal effects during cyclophosphamide and irradiation therapy. Ann Intern Med 1971; 74:87.
232 Coates A. Cyclophosphamide in pregnancy. Aust N Z J Obstet Gynaecol 1970; 10:33.
233 Bar-Oz B, Moretti ME, Bishai R, Mareels G, Van Tittelboom T, Verspeelt J, Koren G. Pregnancy outcome after in utero exposure to itraconazole : a prospective cohort study. Am J Obstet Gynecol 2000; 183:617.
235 Pawliger DF, McLean FW, Noyes WD. Normal fetus after cytosine arabinoside therapy. Ann Intern Med 1971; 74:1012.
236 Raich PC, Curet LB. Treatment of acute leukemia during pregnancy. Cancer 1975; 36:861.
237 Gokal R, Durrant J, Baum JD, Bennett MJ. Successful pregnancy in acute monocytic leukaemia. Br J Cancer 1976; 34:299.
238 Durie BG, Giles HR. Successful treatment of acute leukemia during pregnancy. Combination therapy in the third trimester. Arch Intern Med 1977; 137:90.
239 Lilleyman JS, Hill AS, Anderton KJ. Consequences of acute myelogenous leukemia in early pregnancy. Cancer 1977; 40:1300.
240 Newcomb M, Balducci L, Thigpen JT, Morrison FS. Acute leukemia in pregnancy. Successful delivery after cytarabine and doxorubicin. JAMA 1978; 239:2691.
241 Pizzuto J, Aviles A, Noriega L, Niz J, Morales M, Romero F. Treatment of acute leukemia during pregnancy: presentation of nine cases. Cancer Treat Rep 1980; 64:679.
242 Dara P, Slater LM, Armentrout SA. Successful pregnancy during chemotherapy for acute leukemia. Cancer 1981; 47:845.
243 Plows CW. Acute myelomonocytic leukemia in pregnancy: report of a case. Am J Obstet Gynecol 1982; 143:41.
244 Feliu J, Juarez S, Ordonez A, Garcia-Paredes ML, Gonzalez-Baron M, Montero JM. Acute leukemia and pregnancy. Cancer 1988; 61:580.
245 Caligiuri MA, Mayer RJ. Pregnancy and leukemia. Semin Oncol 1989; 16:388.
246 Maurer LH, Forcier RJ, McIntyre OR, Benirschke K. Fetal group C trisomy after cytosine arabinoside and thioguanine. Ann Intern Med 1971; 75:809.
247 Wagner VM, Hill JS, Weaver D, Baehner RL. Congenital abnormalities in baby born to cytarabine treated mother. The Lancet 1980; 2:98.
248 Schafer AI. Teratogenic effects of antileukemic chemotherapy. Arch Intern Med 1981; 141:514.
249 Russell JA, Powles RL, Oliver RT. Conception and congenital abnormalities after chemotherapy of acute myelogenous leukaemia in two men. Br Med J 1976; 1:1508.
250 Milunsky A, Graef JW, Gaynor MF Jr. Methotrexate-induced congenital malformations. J Pediatr 1968; 72:790.
251 Powell HR, Ekert H. Methotrexate-induced congenital malformations. Med J Aust 1971; 2:1076.
252 Gililland J, Weinstein L. The effects of cancer chemotherapeutic agents on the developing fetus. Obstet Gynecol Surv 1983; 38:6.
253 Haerr RW, Pratt AT. Multiagent chemotherapy for sarcoma diagnosed during pregnancy. Cancer 1985; 56:1028.
254 Sears HF, Reid J. Granulocytic sarcoma: local presentation of a systemic disease. Cancer 1976; 37:1808.
255 Tobias JS, Bloom HJ. Doxorubicin in pregnancy. The Lancet 1980; 1:776.
256 Sanz MA, Rafecas FJ. Successful pregnancy during chemotherapy for acute promyelocytic leukemia. N Engl J Med 1982; 306:939.
257Turchi JJ, Villasis C. Anthracyclines in the treatment of malignancy in pregnancy. Cancer 1988; 61:435.
258 Armstrong JG, Dyke RW, Fouts PJ, Jansen CJ. Delivery of a normal infant during the course of oral vinblastine sulfate therapy for Hodgkin's disease. Ann Intern Med 1964; 61:106.
259 Rosenzweig AI, Crews QE Jr, Hopwood HG. Vinblastine sulfate in Hodgkin's disease in pregnancy. Ann Intern Med 1964; 61:108.
260 Lacher MJ. Use of vinblastine sulfate to treat Hodgkin's disease during pregnancy. Ann Intern Med 1964; 61:113.
261 Nordlund JJ, DeVita VT, Cabbone PP. Severe vinblastine-induced leukopenia during late pregnancy with delivery of a normal infant. Ann Intern Med 1968; 69:581.
262 Nisce LZ, Tome MA, He S, Lee BJ 3rd, Kutcher GJ. Management of coexisting Hodgkin's disease and pregnancy. Am J Clin Oncol 1986; 9:146.
263 Garrett MJ. Letter: Teratogenic effects of combination chemotherapy. Ann Intern Med 1974; 80:667.
264 Thomas PR, Biochem D, Peckham MJ. The investigation and management of Hodgkin's disease in the pregnant patient. Cancer 1976; 38:1443.
265 Okun DB, Groncy PK, Sieger L, Tanaka KR. Acute leukemia in pregnancy: transient neonatal myelosuppression after combination chemotherapy in the mother. Med Pediatr Oncol 1979; 7:315.
266 Jacobs AJ, Marchevsky A, Gordon RE, Deppe G, Cohen CJ. Oat cell carcinoma of the uterine cervix in a pregnant woman treated with cis-diamminedichloroplatinum. Gynecol Oncol 1980; 9:405.
267 Raffles A, Williams J, Costeloe K, Clark P. Transplacental effects of maternal cancer chemotherapy. Case report. Br J Obstet Gynaecol 1989; 96:1099.
268 Malfetano JH, Goldkrand JW. Cis-platinum combination chemotherapy during pregnancy for advanced epithelial ovarian carcinoma. Obstet Gynecol 1990; 75:545.
269 Buller RE, Darrow V, Manetta A, Porto M, DiSaia PJ. Conservative surgical management of dysgerminoma concomitant with pregnancy. Obstet Gynecol 1992; 79:887.
270 Chaube S. Protective effects of thymidine, 5-aminoimidazolecarboxamide, and riboflavin against fetal abnormalities produced in rats by 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide. Cancer Res 1973; 33:2231.
271 Baer MR, Ozer H, Foon KA. Interferon-alpha therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia. Br J Haematol 1992; 81:167.
272 Lee IP, Dixon RL. Mutagenicity, carcinogenicity and teratogenicity of procarbazine. Mutat Res 1978; 55:1.
273 Mennuti MT, Shepard TH, Mellman WJ. Fetal renal malformation following treatment of Hodgkin's disease during pregnancy. Obstet Gynecol 1975; 46:194.
274 Wells JH, Marshall JR, Carbone PP. Procarbazine therapy for Hodgkin's disease in early pregnancy. JAMA 1968; 205:935.
275 Benke PJ. The isotretinoin teratogen syndrome. JAMA 1984; 251:3267.
276 Retinoic acid embryopathy. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, Curry CJ, Fernhoff PM, Grix AW Jr, Lott IT, et al. N Engl J Med 1985; 313:837.
277 Wolff J. Iodide goiter and the pharmacologic effects of excess iodide. Am J Med 1969; 47:101.
278 Herbst AL, Selenkow HA. Hyperthyroidism during pregnancy. N Engl J Med 1965; 273:627.
279 De Santis M, Carducci B, De Santis L, Cavaliere AF, Straface G. Periconceptional exposure to efavirenz and neural tube defects. Arch Intern Med 2002; 162:355.
280 Commission clinique et thérapie VIH/sida. Grossesse et VIH: recommandations de la CCT pour la prévention de la transmission verticale du VIH. Bulletin OFSP 2004; 53:1008.
281 Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. The Lancet Oncol 2004; 5:283.
282 Nguyen C, Duhl AJ, Escallon CS, Blakemore KJ. Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester. Obstet Gynecol 2002; 99:599.
283 Ostensen M, Hartmann H, Salvesen K. Low dose weekly methotrexate in early pregnancy. A case series and review of the literature. J Rheumatol 2000; 27:1872.
284 Bar-Oz B, Levichek Z, Moretti ME, Mah C, Andreou S, Koren G. Pregnancy outcome following rubella vaccination. Am J Med Genet A 2004; 130:52.
285 Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004; 99:2385.
286 Le Ray C, Coulomb A, Elefant E, Frydman R, Audibert F. Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations. Obstet Gynecol 2004; 103:1091.
287 Brent RL. Teratogen update: reproductive risks of leflunomide (Arava) a pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child. Teratology 2001; 63:106.
288 Shapiro L, Pastuszak A, Curto G, Koren G. Safety of first-trimester exposure to topical tretinoin: prospective cohort study. The Lancet 1997; 350:1143.
289 French AE, Kaplan N, Lishner M, Koren G. Taking bisphosphonates during pregnancy. Can Fam Physician 2003; 49:1281.
290 De Santis M, Lucchese A, Carducci B, Cavaliere AF, De Santis L, Merola A, Straface G, Caruso A. Latanoprost exposure in pregnancy. Am J Ophthalmol 2004; 138:305.
291 Ben-Chetrit E, Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis 2003; 62:916.
292 Kuczkowski KM. Nonobstetric surgery during pregnancy : what are the risks of anesthesia ?. Obstet Gynecol Surv 2004; 59:52.
293 Achtari C, Hohlfeld P. Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy. Am J Obstet Gynecol 2000; 183:511.
294 Watson WJ. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstet Gynecol 2005; 105:642.
295 Webb JAW, Thomsen HS, Morcos SK. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 2005; 15:1234.
296 American College of Obstetricians and Gynecologists. ACOG Committee Opinion. Immunization during pregnancy. Obstet Gynecol 2003; 101:207.
